Filing Details
- Accession Number:
- 0001209191-19-060108
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-12-11 19:15:34
- Reporting Period:
- 2019-12-09
- Accepted Time:
- 2019-12-11 19:15:34
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1016169 | Antares Pharma Inc. | ATRS | Surgical & Medical Instruments & Apparatus (3841) | 411350192 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1054942 | F Robert Apple | C/O Antares Pharma, Inc. 100 Princeton South, Suite 300 Ewing NJ 08628 | President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-12-09 | 100,000 | $1.52 | 2,005,891 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-12-09 | 100,000 | $4.68 | 1,905,891 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2019-12-09 | 97,000 | $1.66 | 2,002,891 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-12-09 | 97,000 | $4.62 | 1,905,891 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2019-12-09 | 110,000 | $2.94 | 2,015,891 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-12-09 | 110,000 | $4.58 | 1,905,891 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2019-12-09 | 1,000 | $3.96 | 1,906,891 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-12-09 | 1,000 | $4.75 | 1,905,891 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2019-12-10 | 58,524 | $3.96 | 1,964,415 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-12-10 | 58,524 | $4.76 | 1,905,891 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2019-12-09 | 100,000 | $0.00 | 100,000 | $1.52 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2019-12-09 | 97,000 | $0.00 | 97,000 | $1.66 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2019-12-09 | 110,000 | $0.00 | 110,000 | $2.94 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2019-12-09 | 1,000 | $0.00 | 1,000 | $3.96 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2019-12-10 | 58,524 | $0.00 | 58,524 | $3.96 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2020-11-10 | No | 4 | M | Direct | |
| 0 | 2021-05-16 | No | 4 | M | Direct | |
| 0 | 2022-05-16 | No | 4 | M | Direct | |
| 0 | 2023-05-21 | No | 4 | M | Direct | |
| 0 | 2023-05-21 | No | 4 | M | Direct |
Footnotes
- The options vested and became exercisable in equal quarterly installments over the three-year period following the grant date of November 11, 2010.
- The options vested and became exercisable in equal quarterly installments over the three-year period following the grant date of May 17, 2011.
- The options vested and became exercisable in equal quarterly installments over the three-year period following the grant date of May 17, 2012.
- The options vested and became exercisable in equal quarterly installments over the three-year period following the grant date of May 22, 2013.
Billionaire Hedge Funds
